Summary

Venus Remedies Limited (Venus) is a pharmaceutical company. It develops, manufactures and commercializes pharmaceutical products. The company, through its research centre Venus Medicine Research Centre, provides novel solutions for unmet medical needs in the fields of field of oncology, anti-microbial resistance, wound care and pain management. Its products include Elores, Vancoplus, Potentox, Tobracef, Supime, Zydotum, and Pirotum, among others. Venus's products are used in various therapeutic areas such as anti cancer, anti infective, neurology, skin & wound care, and pain management, neurology and OTC. The company has three injectable manufacturing units in Panchkula, Baddi (both India) and Werne (Germany). It has operational presence in Germany and India through its 11 overseas marketing offices. Venus is headquartered in Panchkula, Haryana, India.

Venus Remedies Limited Key Recent Developments

Feb 04, 2014: Venus receives Indonesian GMP for its Baddi unit
Nov 03, 2012: Venus Remedies Reports Revenue Of INR1.1 Billion In Q2 Fiscal 2013
Aug 03, 2012: Venus Remedies Reports Revenue Of INR1.1 Billion In Q1 Fiscal 2013
May 04, 2012: Venus Remedies Reports Revenue Of INR1.1 Billion In Q4 Fiscal 2012
Apr 24, 2012: Venus Remedies Establishes Pre-Clinical Proof Of Concept For Drug-Protein-Polymer- Conjugate

This comprehensive SWOT profile of Venus Remedies Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including*,



- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table Of Contents

Table of Contents

Section 1 - About the Company

Venus Remedies Limited - Key Information
Venus Remedies Limited - Overview
Venus Remedies Limited - Key Employees
Venus Remedies Limited - Key Employee Biographies
Venus Remedies Limited - Key Operational Heads
Venus Remedies Limited - Major Products and Services
Venus Remedies Limited - History
Venus Remedies Limited - Company Statement
Venus Remedies Limited - Locations And Subsidiaries
Venus Remedies Limited - Key Manufacturing facilities
Head Office
Other Locations and Subsidiaries

Section 2 - Company Analysis

Venus Remedies Limited - Business Description
Venus Remedies Limited - Corporate Strategy
Venus Remedies Limited - SWOT Analysis
SWOT Analysis - Overview
Venus Remedies Limited - Strengths
Venus Remedies Limited - Weaknesses
Venus Remedies Limited - Opportunities
Venus Remedies Limited - Threats
Venus Remedies Limited - Key Competitors

Section 3 - Company Financial Performance Charts

Venus Remedies Limited - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Venus Remedies Limited, Key Information
Venus Remedies Limited, Key Ratios
Venus Remedies Limited, Share Data
Venus Remedies Limited, Major Products and Services
Venus Remedies Limited, History
Venus Remedies Limited, Key Employees
Venus Remedies Limited, Key Employee Biographies
Venus Remedies Limited, Key Operational Heads
Venus Remedies Limited, Other Locations
Venus Remedies Limited, Subsidiaries
Venus Remedies Limited, Key Manufacturing facilities
Venus Remedies Limited, Key Competitors
Venus Remedies Limited, SWOT Analysis
Venus Remedies Limited, Ratios based on current share price
Venus Remedies Limited, Annual Ratios
Venus Remedies Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Tables

Venus Remedies Limited, Performance Chart
Venus Remedies Limited, Ratio Charts

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Shoppers Drug Mart-Canada

Shoppers Drug Mart-Canada

  • $ 9 141
  • Company report
  • December 2014
  • by PureData

Description of Content of Retailer Reports The report consist of a main PDF file of about 450 pages, about 9500 web pages, about 14,500 spreadsheets, about 14,500 database tables, and a large number of ...

Biopharmaceutical Industry: AlphaVax, Inc. – Product Pipeline Review – Q2 2011

Biopharmaceutical Industry: AlphaVax, Inc. – Product Pipeline Review – Q2 2011

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

- Product Pipeline Review - Q2 2011” provides a detailed overview on the AlphaVax, Inc.’s research and development focus. The report includes data on current developmental pipeline, complete with latest ...

Pathology in Japan: Eisai Co., Ltd. – Product Pipeline Review – H2 2011

Pathology in Japan: Eisai Co., Ltd. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

Ltd. - Product Pipeline Review - H2 2011” provides a detailed overview on the Eisai Co., Ltd.’s research and development focus. The report includes data on current developmental pipeline, complete ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.